265 related articles for article (PubMed ID: 3675502)
1. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
2. The effect of antimotion sickness drugs on habituation to motion.
Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of ginger with various antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
5. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for motion sickness: cardiovascular effects.
Sunahara FA; Farewell J; Mintz L; Johnson WH
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
[TBL] [Abstract][Full Text] [Related]
7. Human assay of antimotion sickness drugs.
Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
[TBL] [Abstract][Full Text] [Related]
8. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
Collins WE; Schroeder DJ; Elam GW
Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
[TBL] [Abstract][Full Text] [Related]
9. Effect of transdermally administered scopolamine in preventing motion sickness.
McCauley ME; Royal JW; Shaw JE; Schmitt LG
Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe motion sickness with antimotion sickness drug injections.
Graybiel A; Lackner JR
Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537
[TBL] [Abstract][Full Text] [Related]
11. Effectivity of antimotion sickness drugs during artificial gravity simulations.
Green JA
Aerosp Med; 1973 Nov; 44(11):1255-60. PubMed ID: 4586812
[No Abstract] [Full Text] [Related]
12. Effects of some motion sickness suppressants on static and dynamic tracking performance.
Schroeder DJ; Collins WE; Elam GW
Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
[TBL] [Abstract][Full Text] [Related]
13. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
Noy S; Shapira S; Zilbiger A; Ribak J
Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
[TBL] [Abstract][Full Text] [Related]
14. Side effects of antimotion sickness drugs.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
[TBL] [Abstract][Full Text] [Related]
15. Various anti-motion sickness drugs and core body temperature changes.
Cheung B; Nakashima AM; Hofer KD
Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398
[TBL] [Abstract][Full Text] [Related]
16. Diazepam as an anti-motion sickness drug.
McClure JA; Lycett P; Baskerville JC
J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and duration of intramuscular antimotion sickness medications.
Wood CD; Stewart JJ; Wood MJ; Mims M
J Clin Pharmacol; 1992 Nov; 32(11):1008-12. PubMed ID: 1474161
[TBL] [Abstract][Full Text] [Related]
18. Experimental research on antimotion sickness effects of Chinese medicine "pingandan" pills in cats.
Pei JS; Tong BL; Chen KJ; Li CS; Zhang GX
Chin Med J (Engl); 1992 Apr; 105(4):322-7. PubMed ID: 1618017
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
[TBL] [Abstract][Full Text] [Related]
20. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
Muth ER; Elkins AN
Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
